Answers are grounded in this paper and cite their sources.
Background: SARS coronavirus 2 is the causative agent of the newly emerging respiratory infection known as coronavirus disease 2019 (COVID19). There are several studies outside of India demonstrating an increase in new-onset diabetes among COVID-19 illness patients, but just a handful in India. Present study was carried, reveal a link between RBS and HbA1c in COVID-19 patients' relation with age, gender, co morbidities, addictions and outcomes in covid 19 positive patients. Objective: To study the correlation between RBS and HbA1c nding in patient with Covid - 19 positive status admitted in Civil Hospital Ahmedabad. Methodology: Afollow up study was conducted at Medicine Department, Civil Hospital Ahmedabad (1200 bed hospital), among 100 COVID-19 positive patients between September 2020 to September 2021. Data was collected and analysed using Microsoft Excel (licenced version). Results: In this study, the correlation between RBS and HBA1C on the rst day was high positive and statistically signicant (r=0.61, r2=37.21%, p<0.001). On 3rd day the correlation between RBS and HBA1C low positive and statistically signicant (r=0.34, r2=11.56%, p=0.001 . On 7th day the correlation between RBS and HBA1C low positive and statistically signicant (r=0.21, r2=4.41%, p<0.001) . Conclusion: The Random blood sugar was considerably high on the seventh day after admission than on the rst day. The correlation of glycosylated haemoglobin and Random blood sugar on the rst day was highly positive and statistically signicant. The correlation of RBS and HBA1C on the third day and seventh day was low positive and statistically signicant.
No takes yet. Share an insight, caveat, or question.
Upadhyay et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: